NCT02105987 · Interventional trial
A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen
Overall registry status Completed
Phase 3
Conditions Infection, Human Immunodeficiency Virus
Delaware Valley sites
- GSK Investigational Site · Camden, NJ · Camden County
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory